We are live on
!
Find out more
FAF
Fjarde Ap-fonden Portfolio holdings
AUM
$20.9B
1-Year Est. Return
36.93%
This Fund
S&P 500
This Quarter
Est. Return
+1.75%
1 Year Est. Return
+36.93%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$10.8B
AUM Growth
-$76.2M
(-0.7%)
Cap. Flow
-$178M
Cap. Flow
% of AUM
-1.64%
Top 10 Holdings %
Top 10 Hldgs %
28.27%
Holding
568
New
2
Increased
152
Reduced
375
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI USA Value Factor ETF
VLUE
|
+$113M |
| 2 |
Amazon
AMZN
|
+$16.9M |
| 3 |
Snowflake
SNOW
|
+$15.1M |
| 4 |
Palantir
PLTR
|
+$7.78M |
| 5 |
Analog Devices
ADI
|
+$7.35M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$22.8M |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$22.7M |
| 3 |
Microsoft
MSFT
|
+$16.2M |
| 4 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$12.5M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$10.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.75% |
| 2 | Financials | 14.45% |
| 3 | Healthcare | 13.61% |
| 4 | Consumer Discretionary | 11.84% |
| 5 | Communication Services | 11.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Progressive
PGR
$124B
| $16.9M | 0.16% |
187,427
-2,600
| -1% | -$248K |
|
127
Illumina
ILMN
$28.6B
| $16.6M | 0.15% |
42,145
-1,028
| -2% | -$473K |
|
|
ATVI
128
DELISTED
Activision Blizzard
ATVI
| $16.5M | 0.15% |
213,655
-4,500
| -2% | -$376K |
|
129
Emerson Electric
EMR
$88.1B
| $16.5M | 0.15% |
175,518
-6,700
| -4% | -$669K |
|
130
Eaton
ETN
$175B
| $16.4M | 0.15% |
110,007
-14,500
| -12% | -$2.32M |
|
131
Marvell Technology
MRVL
$193B
| $16.3M | 0.15% |
270,017
-2,372
| -0.9% | -$142K |
|
132
FedEx
FDX
$74.7B
| $15.9M | 0.15% |
72,504
-2,100
| -3% | -$570K |
|
133
Workday
WDAY
$41.5B
| $15.8M | 0.15% |
63,328
+649
| +1% | +$161K |
|
134
Ford
F
$55.7B
| $15.7M | 0.14% |
1,105,897
+10,600
| +1% | +$144K |
|
135
lululemon athletica
LULU
$14.2B
| $15.6M | 0.14% |
38,456
-2,204
| -5% | -$883K |
|
136
CSX Corp
CSX
$94.5B
| $15.5M | 0.14% |
522,773
-76,900
| -13% | -$2.46M |
|
|
INFO
137
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $15.4M | 0.14% |
132,089
-5,100
| -4% | -$602K |
|
138
MetLife
MET
$63.7B
| $15.3M | 0.14% |
247,659
-4,500
| -2% | -$271K |
|
139
MSCI
MSCI
$41.3B
| $14.8M | 0.14% |
24,295
-1,095
| -4% | -$669K |
|
140
Humana
HUM
$43B
| $14.7M | 0.14% |
37,838
-800
| -2% | -$340K |
|
141
Zoom
ZM
$29.4B
| $14.7M | 0.14% |
56,300
+1,000
| +2% | +$337K |
|
142
IQVIA
IQV
$37.9B
| $14.6M | 0.13% |
60,965
-2,400
| -4% | -$606K |
|
143
DexCom
DXCM
$31.3B
| $14.6M | 0.13% |
106,812
-400
| -0.4% | -$50.4K |
|
144
Prudential Financial
PRU
$41.5B
| $14.3M | 0.13% |
135,838
-6,200
| -4% | -$639K |
|
145
Johnson Controls International
JCI
$93.6B
| $14.2M | 0.13% |
208,526
-15,400
| -7% | -$1.11M |
|
146
KLA
KLAC
$257B
| $14.2M | 0.13% |
424,000
-6,000
| -1% | -$200K |
|
147
Idexx Laboratories
IDXX
$46B
| $14M | 0.13% |
22,574
-300
| -1% | -$202K |
|
148
NXP Semiconductors
NXPI
$59.4B
| $14M | 0.13% |
71,675
-3,200
| -4% | -$665K |
|
149
TE Connectivity
TEL
$62.7B
| $14M | 0.13% |
101,815
-2,800
| -3% | -$404K |
|
150
Palo Alto Networks
PANW
$291B
| $13.9M | 0.13% |
174,288
-9,000
| -5% | -$632K |
|
Similar funds
MMH
VARA
SC
CB
MIC
GT
Fjarde Ap-fonden's Q3 2021 Portfolio in Review
As of Q3 2021, Fjarde Ap-fonden held 568 positions worth $10.8B, down 0.7% from $10.9B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Trading was light in Q3 2021: portfolio turnover was 1.9%. Fjarde Ap-fonden opened 2 new positions and exited 9, leaving the 568-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.
- Fjarde Ap-fonden's largest Q3 2021 buy was DoorDash: 26,300 shares worth $5.42M.
- Fjarde Ap-fonden added most to iShares MSCI USA Value Factor ETF in Q3 2021, an estimated $113M increase.
- Fjarde Ap-fonden's biggest Q3 2021 reduction was Apple, cutting an estimated $22.8M.
- Fjarde Ap-fonden fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $12.5M.
- Fjarde Ap-fonden's ten largest holdings make up 28% of its $10.8B portfolio in Q3 2021.
- Fjarde Ap-fonden opened 2 new positions and closed 9 in Q3 2021.
- Fjarde Ap-fonden's portfolio value fell 0.7% quarter-over-quarter to $10.8B.
Based on Fjarde Ap-fonden's 13F filing for Q3 2021, filed 15 Nov 2021.